The latest price target for Kala Bio (NASDAQ:KALA) was reported by HC Wainwright & Co. on November 15, 2024. The analyst firm set a price target for $15.00 expecting KALA to rise to within 12 months (a possible 145.50% upside). 5 analyst firms have reported ratings in the last year.

The latest analyst rating for Kala Bio (NASDAQ:KALA) was provided by HC Wainwright & Co., and Kala Bio reiterated their buy rating.

There is no last upgrade for Kala Bio

The last downgrade for Kala Bio Inc happened on March 30, 2022 when JP Morgan changed their price target from N/A to $1.5 for Kala Bio Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Kala Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Kala Bio was filed on November 15, 2024 so you should expect the next rating to be made available sometime around November 15, 2025.

While ratings are subjective and will change, the latest Kala Bio (KALA) rating was a reiterated with a price target of $15.00 to $15.00. The current price Kala Bio (KALA) is trading at is $6.11, which is out of the analyst’s predicted range.